TRAILBLAZER-ALZ trial data reveal that modified donanemab dosing reduces ARIA risk in early Alzheimer’s disease, with ...

Explore the impact of functional respiratory tests on outcomes in anti-CD19 CAR T-cell therapy, presented at EBMT 2025.

Discover the long-term results of CAR T-cell therapy, with and without stem cell transplantation, for relapsed lymphoma ...

Explore the promising results of haematopoietic stem cell transplantation as a treatment for early-onset inflammatory bowel ...

A landmark migraine study presented at AAN 2025 identified 778 new genetic variants linked to migraine across ancestries in ...

Despite its prevalence, the exact mechanisms driving MASLD remain unclear, limiting the development of effective treatments.

Discover the latest findings on transplantation outcomes in Myelodysplastic Syndrome and Acute Myeloid Leukaemia from EBMT ...

A pilot study presented at EBMT 2025 shows adoptive cell therapy using memory T lymphocytes effectively treats infections in ...

Discover how maintenance therapy improves transplant outcomes for high-risk AML patients, with key insights from EBMT 2025.

How pharma could shift from curing disease to promoting healthy ageing through epigenetics, the microbiome and antimicrobial ...

Discover how task-technology fit shapes adoption of intelligence-enabled diagnostic clinical decision support systems in ...

A novel method combining EHR and GWAS data improves prediction of autoimmune disease progression from preclinical stages, ...